LIGAND PHARMACEUTICALS INC's ticker is LGND and the CUSIP is 53220K504. A total of 269 filers reported holding LIGAND PHARMACEUTICALS INC in Q4 2019. The put-call ratio across all filers is 1.95 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $652 | -68.9% | 8,872 | -71.8% | 0.01% | -73.3% |
| Q4 2022 | $2,098 | -99.8% | 31,420 | +136.2% | 0.03% | +150.0% |
| Q3 2022 | $1,145,000 | -26.5% | 13,305 | +31.9% | 0.01% | +33.3% |
| Q4 2021 | $1,558,000 | +7.9% | 10,088 | +6.5% | 0.01% | -40.0% |
| Q1 2021 | $1,444,000 | +473.0% | 9,472 | +319.9% | 0.02% | +87.5% |
| Q2 2020 | $252,000 | +21.2% | 2,256 | +7.7% | 0.01% | -20.0% |
| Q3 2019 | $208,000 | -73.7% | 2,095 | -69.7% | 0.01% | -80.0% |
| Q2 2019 | $790,000 | – | 6,921 | – | 0.05% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Knott David M Jr | 115,000 | $12,937,000 | 4.12% |
| Stonepine Capital Management, LLC | 73,700 | $8,291,000 | 3.44% |
| VILLERE ST DENIS J & CO LLC | 510,843 | $57,464,000 | 3.41% |
| Chicago Capital, LLC | 491,717 | $55,313,000 | 2.38% |
| Orchard Capital Management, LLC | 73,596 | $8,279,000 | 2.35% |
| RICE HALL JAMES & ASSOCIATES, LLC | 344,969 | $38,806,000 | 1.55% |
| Smith, Graham & Co., Investment Advisors, LP | 86,834 | $9,768,000 | 1.02% |
| WOODSTOCK CORP | 64,050 | $7,205,000 | 0.84% |
| INVESTMENT MANAGEMENT OF VIRGINIA LLC | 37,246 | $4,190,000 | 0.74% |
| Stephens Investment Management Group LLC | 417,670 | $46,984,000 | 0.69% |